top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in the Treatment of Renal Cell Carcinoma
Advances in the Treatment of Renal Cell Carcinoma
Autore Reynolds Paul
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (221 p.)
Soggetto topico Medicine
Soggetto non controllato artesunate (ART)
autophagy
biomarker
biomarkers
ccRCC
chloroquine
clear cell renal cell carcinoma
cysteine cathepsin inhibitors
cysteine cathepsins
evolution
evolutionary trajectory
ferroptosis
genomic signature
growth inhibition
hydroxychloroquine
immune checkpoint inhibitors
immune-based combination therapies
immunotherapy
individualization
kidney cancer
lysosome
metastatic
metastatic renal cell carcinoma
mRCC
network meta-analysis
PD-L1
predictive
RCC
reactive oxygen species (ROS)
renal cancer
renal cell cancer
renal cell carcinoma
renal cell carcinoma (RCC)
ROC-325
second line therapy
soluble factors
sunitib resistance
TKIs
Traditional Chinese Medicine (TCM)
transcriptomic analysis
treatment
tyrosine kinase inhibitors
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557615503321
Reynolds Paul  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Immunology
Cancer Immunology
Autore Subramanian Subree
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (316 p.)
Soggetto topico Medicine
Soggetto non controllato adaptive immunity
anti-CD20 antibody
anti-CTLA-4
anti-PD-1
antibody-dependent cellular cytotoxicity (ADCC)
antigen presenting cells
antigen-presenting cells
Atypical Chemokine Receptor 4 (ACKR4)
B cell aplasia
BAP1
BiFab
bispecific antibody
cancer
cancer stem cells (CSCs)
cancer vaccine
CAR T
carcinoma
CD19-CAR-T
CD28
cell therapy
chemo-enzymatic approach
chemotherapy
classical and endemic Kaposi Sarcoma
colon cancer
colorectal cancer
combination immunotherapy
CTLA-4
cytotoxicity
dendritic cells
differentiation
DNA methylation
epidemiologic studies
Fab
IDO inhibitor
IFN-γ
IL-7
IL15
immune checkpoint blockade
immune checkpoint inhibitors
immune checkpoints
immune evasion
immunomodulation
immunosuppression
immunotherapy
indoleamine 2,3 dioxygenase 1
inhibitory CAR
innate immunity
interferon
KIR
kynurenine pathway
m6A
melanoma
MICA/B mAb
multi-state modelling
n/a
NK cells
NKG2D
organ transplantation
osteoclasts
PD-1
PD-L1
primary liver cancer
prostate cancer
resistance
RNA methylation
S-adenosylmethionine (SAM)
sortase A
systemic treatment
T cells
T-cell priming
TCR diversity
TIL
treatment free interval
Treg cells
triple negative breast cancer
tryptophan 2,3 dioxygenase 2
tumor microenvironment
tumor-infiltrating lymphocytes
uveal
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557349203321
Subramanian Subree  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy Response
Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy Response
Autore Ferrao Petranel T
Pubbl/distr/stampa Frontiers Media SA, 2019
Descrizione fisica 1 online resource (186 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato cancer plasticity
Epithelial-to-mesenchymal transition (EMT)
heterogeneity
immune checkpoint inhibitors
Immune Evasion
Immunotherapy
therapy resistance
Tumor microenvironment (TME)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Cancer Plasticity and the Microenvironment
Record Nr. UNINA-9910557266803321
Ferrao Petranel T  
Frontiers Media SA, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination
Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination
Autore Alix-Panabieres Catherine
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (366 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato abiraterone
ACCEPT
androgen receptor
AR
AR-V7
ARV7
biomarker
biomarkers
bone marrow
breast cancer
castration resistant prostate cancer (CRPC)
CD133
CellSearch
CellSearch®
cerebrospinal liquid biopsy
chemoradioresistance
chromogranin A
circulating leukemia cells
circulating plasma cells
circulating tumor cells
circulating tumor cells (CTC)
circulating tumor cells (CTCs)
circulating tumor DNA
circulating tumour cells
clinical trials
clinical utility
colorectal cancer
colorectal surgery
CTC
CTC biology
CTC capture technology
CTC-based treatment decisions
CTC-derived ex vivo models
CTC-derived xenografts
CTCs
ctDNA
CTM
CTMat
ctRNA
disseminated tumor cells
early breast cancer
EasyCount slides
emboli
enrichment and detection technologies
enzalutamide
EpCAM enrichment
EPISPOT
epithelial-mesenchymal transition
epithelial-to-mesenchymal transition (EMT)
exosome
exosomes
fibronectin
fish
flow cytometry
FOLFIRINOX
gene expression analysis
glioma
hematological cells
hepatocellular carcinoma (HCC)
heterogeneity
HMB-45
immune checkpoint inhibitors
immune system
immunofluorescence imaging
immunomodulation
immunophenotyping
in vivo flow cytometry
integrin B1
leukocyte-derived extracellular vesicles
liquid biopsy
liquid surgery
locally advanced rectal cancer
major histocompatibility complex class I (MHCI)
malaria
melanoma
metastasis
metastatic colorectal cancer
microbiome
microfluidics
microsatellite instability
miRNA
n/a
neutrophils
NSCLC
PD-L1 expression
platelets
prostate cancer
prostate cancer (PCa)
RAD23B
rovalpituzumab tesirine
rVAR2
single-cell analysis
SLUG
small-cell lung carcinoma
solid cancers
stem cells
synaptophysin
targeted therapy
thymidylate synthase
tumor biomarkers
tumor cell dissemination
tumor stem cells
tumor-initiating cells (TICs)
xenograft models
ISBN 3-03928-699-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Circulating Tumor Cells
Record Nr. UNINA-9910404091403321
Alix-Panabieres Catherine  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunotherapy, Tumor Microenvironment and Survival Signaling
Immunotherapy, Tumor Microenvironment and Survival Signaling
Autore Golubovskaya Vita
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (376 p.)
Soggetto topico Clinical and internal medicine
Medicine and Nursing
Soggetto non controllato angiogenesis
antigen loss
Autophagy
BCMA
breast cancer
cancer
cancer immunotherapy
cancer metabolism
cancer nanomedicine
cancer stem cells
cancer vaccines
CAR macrophage
CAR T cell
CAR-T
CAR-T cells
cardiotoxicity
CD11
CD18
CD19
CD37
cell therapy
cell-cell contact
check point inhibitors
checkpoint
chemotherapy
chimeric antigen receptor
chimeric antigen receptors
clonogenicity
colorectal cancer
combination therapy
crosstalk
DCLK1
dendritic cells
electroporation
hypoxia
immune checkpoint inhibitor
immune checkpoint inhibitors
immune escape
immunogenic cell death
immunometabolism
immunomodulation
immunomodulators
immunotherapeutic agent
immunotherapies
immunotherapy
lentiviral transduction
lentivirus
leukemia cells
lung metastasis
lymphoma
lytic peptides
macrophages
melanoma
microenvironment
miRNA
mitochondria
mitochondrial transfer
myeloid-derived suppressor cells
n/a
nanoparticles
oncolytic viral therapy
pathogenesis
pediatric solid tumors
personalized medicine
programmed cell death 1 ligand 1
programmed cell death protein 1
regulatory T cells
resistance
risk factors
solid tumors
targeted therapy
targeted treatment
triple-negative breast cancer
tuft cells
tumor
tumor antigen
tumor antigens
tumor immune evasion
tumor microenvironment
tumor stem cells
tumor stroma
tunneling nanotubes
tyrosine kinase inhibitors
β2 integrins
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580205403321
Golubovskaya Vita  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Integrating Clinical and Translational Research Networks-Building Team Medicine - Series 2
Integrating Clinical and Translational Research Networks-Building Team Medicine - Series 2
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2023
Descrizione fisica 1 online resource (230 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato adaptive therapy
advanced soft tissue sarcoma
artificial intelligence
ATM mutation
brain metastases
BRIP1 mutation
cancer disparities
cancer prevention
cancer systems biology
care satisfaction
cisplatin
City of Hope
clinical care network
clinical network systems biology
clinical trials
collaboration
colorectal cancer survivor
combinational therapy
community clinical network
community practice
complex case discussions
continuous therapy
cutaneous cancers
decision support
delivery of health care
drug resistance
drug tolerance
eco-evolutionary
EGFR
emergency utilization
endometrial cancer
epigenetics
genetic/nongenetic
genomic-driven
group behavior
gut microbiome
IDPs
imaging
immune checkpoint inhibitors
immunotherapy
implementation
implementation science
integration
integrative oncology
intermittent therapy
intrinsically disordered proteins
LDCT
leptomeningeal metastases
low dose Ct scans
lung cancer screening
mathematical modeling
melanoma
metastasis-directed therapy
Midwest Sarcoma Trials Partnership
minority health
multidisciplinary tumor board
n/a
NET VITALS
neuroendocrine tumors
non-small cell lung cancer
Olaparib
oligometastatic
oncology
oncology pathways
oncolytic virotherapy
pandemic
PARP inhibition
pathologic complete response
pathways to success
personalized medicine
phase 1
phenotype switching
POLE mutation
precision medicine
prostate cancer
PSMA PET
RAD51C mutation
renal cell carcinoma
sarcoma treatment
SARS-CoV-2
self-assessment
smoking cessation
subspecialty expertise
T-VEC
targeted therapy
team medicine
Team Medicine
TMB high
tobacco control
translational research
tumor board
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910743279303321
MDPI - Multidisciplinary Digital Publishing Institute, 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
MicroRNA and Cancer
MicroRNA and Cancer
Autore Tucci Paola
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (298 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato 2'-O-methylation
adipokines
B-CLL
bioinformatics analysis
biomarker
blood biomarker
brain tumour
breast cancer
Breast cancer
cancer stem cell
cancer stem cells
ccRCC
circulating biomarkers
circulating microRNA
colon cancer
Cyclooxygenase-2 (COX-2)
deformability
diagnosis
endometrial cancer
estrogens
exosome
head and neck squamous cell carcinoma
hepatocellular carcinoma
hyperinsulinemia
Hypoxia inducible factor 1-alpha (HIF-1α)
immune checkpoint inhibitors
immunotherapy
insulin
insulin resistance
insulin signaling
insulin-like growth factors
malignant melanoma
medulloblastoma
meta-analysis
metastasis
metastatic melanoma
methylation
microRNA
MicroRNA (miRNA)
microRNAs
Migration
miR-584-5p
miR526b
miR655
miRNA
miRNA-transcription factor network
miRNAs
n/a
non-small cell lung cancer
normal B-cell development
ovarian cancer
Oxidative stress
PARP
PI3K/Akt
plasma
prediction
prognosis
prognostic factor
progression
Prostaglandin E2 receptor 4 (EP4)
pseudouridylation
RCC
regulation
renal cancer
replication stress
serum LDH
smoking
snoRNA
stem cells
stemness
subgroups
survival
targeted therapy
therapy
YKT6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580213503321
Tucci Paola  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Pathways in Cancers
Molecular Pathways in Cancers
Autore Cristóbal Ion
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (284 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato acetylation
actin cytoskeletal reorganization
adaptive immunity
advanced ovarian cancer
anti-receptor therapy
BET inhibitors
biomarkers
bladder cancer initiation
breast cancer
CALR
cancer
cancer immunology
cancer therapeutics
carcinogenicity
CD99 agonist
complement system
DUSP1
EGFR dimerization
endocytosis
epigenetic
epigenome
epithelial cells
FAK dephosphorylation
genome
glioblastoma
gp120
hepatocellular carcinoma
human immunodeficiency virus type 1
immune checkpoint inhibitors
immune evasion
immunotherapy
innate immunity
JAK2
luminal breast cancer
MAPK
matrix protein p17
metastasis
metastatic melanoma
methylation
migration and invasion
mitochondria
molecular targeted agents
MPL
MS-determined phosphopeptides
mTOR
myeloproliferative neoplasms
n/a
Nef
NIMA-related kinase 1 (NEK1)
non-coding RNA
OMD
oncogenic signaling pathway
ovarian cancer
oxidative stress
OXPHOS
pancreatic ductal adenocarcinoma
partial EMT
patient survival
pBRD4
PI3K
PP2A
PRELP
prognosis
prostate cancer
PTPN12
Rac1
reactive oxygen species
resistance
reverse transcriptase
RhoA
SET
signaling pathways
small-cell lung cancer
Snail
splicing pathway
TAK-228
Tat
thioridazine (THD)
tight junction
tousled-like kinase (TLK)
TPOR
trastuzumab
tripeptide
triple negative breast cancer
triple-negative breast cancer
tumor immune microenvironment
tumor microenvironment
tumor suppression gene
Warburg effect
yes-associated protein 1 (YAP1)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566473703321
Cristóbal Ion  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Strategies Aimed to Boost NK Cell-based Immunotherapy of Cancer
Molecular Strategies Aimed to Boost NK Cell-based Immunotherapy of Cancer
Autore Cifaldi Loredana
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 online resource (146 p.)
Soggetto topico Immunology
Medicine and Nursing
Soggetto non controllato adoptive transfer of NK and CAR-NK cells
cancer immunotherapy
immune checkpoint inhibitors
ligands for NK cell-activating receptors
NK cell-based immunotherapy
NK cells
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557249903321
Cifaldi Loredana  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Multimodality Treatments in Metastatic Gastric Cancer
Multimodality Treatments in Metastatic Gastric Cancer
Autore Petrillo Angelica
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (162 p.)
Soggetto topico Medicine
Soggetto non controllato advanced gastric cancer
biomarkers
body composition
bone flare
CAR T cell therapy
cfDNA
circulating tumor cell
conversion surgery
ctDNA
epithelial-mesenchymal transition
Epstein Barr Virus
exome sequencing
formalin fixed paraffin embedded
gastric cancer
gastro-oesophageal cancer
hepatectomy
HER2-inhibition
immune checkpoint inhibitors
immunotherapy
liquid biopsy
liver metastasis
metastatic
metastatic gastric cancer
microsatellite instability
mutational concordance
n/a
new drug development
nutritional status
outcome
precision medicine
predictive biomarkers
RANK-L
resistance to treatment
response monitoring
sarcopenia
stage IV
stage iv gastric cancer
subcutaneous fat area
target therapy
toxicity
treatment
tumor mutational burden
vaccines
VEGFR-inhibition
visceral fat area
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557390503321
Petrillo Angelica  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui